Updates

Updates

Schermafbeelding-2021-03-08-om-16.43.59

March 8, 2021

Upcoming events

In the next weeks Frame will present at different virtual events about Whole Framome cancer vaccination. Our CEO Ronald Plasterk will attend Innovation for Health and CSO Wigard Kloosterman the Europe NEOANTIGEN Summit 2021. 

newsitem-eurostars

December 15, 2020

December 15, 2020

eTheRNA immunotherapies & Frame Therapeutics collaboration is awarded with Eurostars research grant

eTheRNA immunotherapies & Frame Therapeutics collaboration is awarded with Eurostars research grant

A collaborative project between eTheRNA immunotherapies NV and Frame Therapeutics has been awarded a Eurostars grant totalling EUR 1.9 million for the development of a therapeutic vaccine for the treatment of kidney cancer. The Eurostars program aims to stimulate partnerships between European SMEs and start-ups to foster international collaboration and development of innovative technologies.

A collaborative project between eTheRNA immunotherapies NV and Frame Therapeutics has been awarded a Eurostars grant totalling EUR 1.9 million for the development of a therapeutic vaccine for the treatment of kidney cancer. The Eurostars program aims to stimulate partnerships between European SMEs and start-ups to foster international collaboration and development of innovative technologies.

newsitem-eu

May 6, 2020

May 6, 2020

Consortium Frame Therapeutics, Amsterdam UMC and UMC Groningen receives ERDF grant to develop cancer vaccines

Consortium Frame Therapeutics, Amsterdam UMC and UMC Groningen receives ERDF grant to develop cancer vaccines

A collaboration project between Frame Therapeutics and two clinical parties from the University Medical Centers in Amsterdam (Amsterdam UMC) and Groningen (UMCG) with a total research budget of 1.2 million Euros has received the Kansen voor West grant to cover 40% of the project named ‘Framome’. Kansen voor West is a subsidy that is part of the European Regional Development Fund (ERDF).

A collaboration project between Frame Therapeutics and two clinical parties from the University Medical Centers in Amsterdam (Amsterdam UMC) and Groningen (UMCG) with a total research budget of 1.2 million Euros has received the Kansen voor West grant to cover 40% of the project named ‘Framome’. Kansen voor West is a subsidy that is part of the European Regional Development Fund (ERDF).

newsitems-etherna

April 22, 2020

April 22, 2020

Frame announces research collaboration with eTheRNA immunotherapies NV

Frame announces research collaboration with eTheRNA immunotherapies NV

Frame Therapeutics happily announces a new research collaboration with eTheRNA immunotherapies NV (eTheRNA) to develop mRNA cancer vaccines against immunogenic neoantigens.

Frame Therapeutics happily announces a new research collaboration with eTheRNA immunotherapies NV (eTheRNA) to develop mRNA cancer vaccines against immunogenic neoantigens.

Earlier updates

funding

September 13th, 2019

September 13th, 2019

Frame successfully closes funding round

Frame successfully closes funding round

We are happy to report that Frame has found private investors, which will allow to bring the work into clinical testing.

We are happy to report that Frame has found private investors, which will allow to bring the work into clinical testing.

European_Commission.svg

July 15th, 2019

July 15th, 2019

Frame Therapeutics receives prestigious SME instruments grant for starting companies

Frame Therapeutics receives prestigious SME instruments grant for starting companies

Based on a proposal ranked 'excellent', Frame Therapeutics B.V. obtained an SME instruments phase I grant to strengthen their business strategy towards market entry with personalized and off-the-shelf cancer vaccines for all cancer patients. Frame’s proposal scored in the top 5% out of almost 3,000 proposals submitted in this SME instruments funding round.

Based on a proposal ranked 'excellent', Frame Therapeutics B.V. obtained an SME instruments phase I grant to strengthen their business strategy towards market entry with personalized and off-the-shelf cancer vaccines for all cancer patients. Frame’s proposal scored in the top 5% out of almost 3,000 proposals submitted in this SME instruments funding round.

Schermafbeelding 2020-12-17 om 17.50.41

April 29th, 2019

April 29th, 2019

Paper on Frames in Nature Scientific Reports

Paper on Frames in Nature Scientific Reports

A Scientific Report by Koster and Plasterk, published on April 29th 2019, describes frame shifts in tumor driver genes. The frame shift mutations were found in public databases of over 10,000 different tumors from different cancer patients. These patients have nothing in common, except that they all have one or another form of cancer; that is the reason that they often have frame shift mutations in a small set of so-called ‘tumor driver’ genes.

A Scientific Report by Koster and Plasterk, published on April 29th 2019, describes frame shifts in tumor driver genes. The frame shift mutations were found in public databases of over 10,000 different tumors from different cancer patients. These patients have nothing in common, except that they all have one or another form of cancer; that is the reason that they often have frame shift mutations in a small set of so-called ‘tumor driver’ genes.

building2

March 21, 2019

March 21, 2019

Opening Matrix VII

Opening Matrix VII

On the 21st of March, Matrix VII has been officially opened -with great festivities- by Amsterdam alderman of Economic Affairs Udo Kock. The building, designed by Ector Hoogstad architects, offers laboratory facilities for high-tech companies. Matrix VII is situated in Amsterdam Science Park. Today Amsterdam Science Park is the center par excellence when science and technology are involved.

On the 21st of March, Matrix VII has been officially opened -with great festivities- by Amsterdam alderman of Economic Affairs Udo Kock. The building, designed by Ector Hoogstad architects, offers laboratory facilities for high-tech companies. Matrix VII is situated in Amsterdam Science Park. Today Amsterdam Science Park is the center par excellence when science and technology are involved.

IMG_4167

February 1, 2019

February 1, 2019

Start at Matrix VII building

Start at Matrix VII building

On the 1st of February Frame was launched in the brand-new Matrix VII building with a bang! The building of Matrix VII is built to become the epicentre of science and biotech.

On the 1st of February Frame was launched in the brand-new Matrix VII building with a bang! The building of Matrix VII is built to become the epicentre of science and biotech.

frame_logo_v2

December 27, 2018

December 27, 2018

Frame founded

Frame founded

On the 27th of December 2018, Frame was officially founded by Ronald Plasterk, Dinko Valerio and Bob Lowenberg. The beginning of a new endeavour!

On the 27th of December 2018, Frame was officially founded by Ronald Plasterk, Dinko Valerio and Bob Lowenberg. The beginning of a new endeavour!

filed

2018

2018

First patents filed

First patents filed

Ronald Plasterk, Founder and CEO of Frame filed the first of a series of patents early 2018. This was the first step to the start of Frame.

Ronald Plasterk, Founder and CEO of Frame filed the first of a series of patents early 2018. This was the first step to the start of Frame.